The United States government is buying enough of a new smallpoxmedicine to treat two million people in the event of a bioterrorism attack, and took delivery of the first shipment of it last week. But the purchase has set off a debate about the lucrative contract, with some experts saying the government is buying too much of the drug at too high a price.
January 26, 2013
Scientists last night ended a voluntary ban on creating mutant forms of bird flu, despite warnings that an accidental release could kill millions of people.
Research into H5N1 transmission stopped a year ago amid fears information about how to create potentially dangerous viruses could be used for bioterrorism.
The self-imposed moratorium came after two teams independently discovered how to mutate the virus so that it could be transmitted through [...]
Bern – 21 Swiss chocolatiers and 18 dairies have received a visit from the U.S. Food and Drug Administration. Background is the fear of bioterrorism.
Reason for the unusual inspection is a new American law (Food Defense), after which the food must be tested at the production and not only on imports as before.
Food Defense – what a nice way, by the FDA (it rimes) to control, the food Production in [...]
Homeland Security Newswire.com
August 27, 2012
The idea that disease and infection might be used as weapons is truly dreadful, but there is plenty of evidence showing that biological weapons have been around since ancient times.
Bioterrorism is nothing new, and although medicines have made the world a safer place against a myriad of old scourges both natural and manmade, it still remains all too easy today to uncork a nasty cloud of [...]
PARIS, France — Scientists who created a mutant virus to explore a key aspect of influenza published their research Wednesday after a four-month storm that brewed fears of bioterrorism and accusations of censorship.
The controversy began in December when teams in the United States and the Netherlands separately said they had engineered a hybrid virus in high-security labs.
Their goal was to understand how a highly lethal strain of flu which spreads [...]
S regulators have approved use of a powerful Johnson & Johnson antibiotic to treat plague, an extremely rare, sometimes-deadly bacterial infection.
The Food and Drug Administration also approved Levaquin, known generically as levofloxacin, to reduce risk of people getting plague after exposure to the bacteria that cause it.
Called Yersinia pestis, the bacteria are considered a potential bioterrorism agent.
Rare but deadly: There are less than 2,000 cases of the plague reported worldwide [...]
February 9, 2012
The bioterrorism expert responsible for censoring scientific research which could lead to the creation of a devastating pandemic has admitted the information “is going to get out” eventually.
Professor Paul Keim, chairman of the US National Science Advisory Board for Biosecurity, controversially recommended that researchers be stopped from publishing the precise mutations needed to transform the H5N1 strain of birdflu virus into a human-transmissible version.
In an exclusive [...]
January 31, 2012
During roughly the same time period that health experts worldwide have been warning that the infamous H5N1 avian flu virus could soon morph into a highly-transmissible, exceedingly-deadly “super strain” capable of killing millions, scientists from around the world have been exposed deliberately developing such a strain in laboratories.
Last month, we reported about research work conducted by Ron Fouchier from Erasmus Medical College in the Netherlands that [...]
December 27, 2011
The United States government has effectively blocked the release of two studies that describe how to create a deadly weaponized H5N1 bird flu after directly funding the research. Did pressure from the alternative media force US government officials to block the results that they had originally funded?
It all began when virologist Ron Fouchier of the Erasmus Medical Center in the Netherlands mutated the H5N1 bird flu virus 5 times, making [...]
The Obama administration is wrestling with the thorny question of whether scientists should inject healthy children with the anthrax vaccine to see whether the shots would safely protect them against a bioterrorism attack.
The other option is to wait until an attack happens and then try to gather data from children whose parents agree to inoculate them in the face of an actual threat.
A key working group of federal advisers in [...]